✦ LIBER ✦
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer: Papandreou CN, Daliani DD, Nix D, Yang H, Madden T, Wang X, Pien CS, Millikan RE, Tu SM, Pagliaro L, Kim J, Adams J, Elliott P, Esseltine D, Petrusich A, Dieringer P, Perez C, Logothetis CJ, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 0427, Houston, TX. J Clin Oncol 2004;22:2108–21
✍ Scribed by Gurkamal Chatta
- Book ID
- 116955676
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 39 KB
- Volume
- 22
- Category
- Article
- ISSN
- 1078-1439
No coin nor oath required. For personal study only.